Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28063750 | 0.83 | TP53 (0.44) | ALDH1A1NPSR1KMT2ATP53CA12 | |
| SCHEMBL28063749 | 0.83 | TP53 (0.44) | ALDH1A1NPSR1KMT2ATP53CA12 | |
| SCHEMBL28274637 | 0.82 | NPSR1 (0.35) | ALDH1A1NPSR1CA12CA1CA2 | |
| SCHEMBL28274638 | 0.82 | NPSR1 (0.35) | ALDH1A1NPSR1CA12CA1CA2 | |
| SCHEMBL28869278 | 0.82 | NPSR1 (0.35) | ALDH1A1NPSR1CA12CA1CA2 | |
| SCHEMBL13696855 | 0.79 | SMN1; SMN2 (0.47) | ALDH1A1GAACA12CA1CA2 | |
| SCHEMBL28330447 | 0.76 | IDH1 (0.38) | ALDH1A1NPSR1CA12CA1CA2 | |
| SCHEMBL28330444 | 0.76 | IDH1 (0.38) | ALDH1A1NPSR1CA12CA1CA2 | |
| SCHEMBL19296834 | 0.75 | CA12 (0.40) | CA12CA1CA2CA9 | |
| SCHEMBL8530137 | 0.74 | LMNA (0.51) | ALDH1A1NPSR1KMT2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110003076-A | Sulfamoyl pyrrole amides derivative and its purposes for being used to treat hepatitis B as drug | 爱尔兰詹森科学公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-105452220-B | Sulfamoyl pyrrole amide derivative and application thereof as medicine for treating hepatitis B | 爱尔兰詹森科学公司 | 2019-01-25 | — | — | CN | disclosed |
| CN-105452220-A | Sulfamoyl pyrrole amide derivative and application thereof as medicine for treating hepatitis B | JANSSEN R&D IRELAND | 2016-03-30 | — | — | CN | disclosed |